Literature DB >> 4356265

Prognostic typing in breast cancer. Further investigation of a necropsy series compared with recent surgical specimens.

B O Maehle, F Hartveit.   

Abstract

A comparison of material from necropsy and surgical series has shown that breast carcinoma of cytological types II and III are rare. The majority of cases are of type I. Of the latter, tumours in TNM stage I were not found in the necropsy series, while infiltrating duct carcinomas of type I TNM stage II were also absent. This suggests that the possibility of surgical cure may be better in type I duct carcinomas in stage II than with other histological types. Prolonged survival in contrast to surgical cure was related to type III tumours irrespective of TNM stage.

Entities:  

Mesh:

Year:  1973        PMID: 4356265      PMCID: PMC477882          DOI: 10.1136/jcp.26.10.784

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Breast cancer: the influence of treatment that fails to cure.

Authors:  V P COLLINS
Journal:  Cancer       Date:  1956 Nov-Dec       Impact factor: 6.860

2.  A comparison of two methods of prognostic typing in breast cancer.

Authors:  D R Turner; C L Berry
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

3.  The autopsy.

Authors:  J Prutting
Journal:  JAMA       Date:  1972-12-18       Impact factor: 56.272

4.  Prognostic typing in breast cancer.

Authors:  F Hartveit
Journal:  Br Med J       Date:  1971-10-30

5.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

  5 in total
  2 in total

1.  Reproducibility of grading systems for breast carcinoma.

Authors:  F Hartveit
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

2.  Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis.

Authors:  B O Maehle; S Thoresen; R Skjaerven; F Hartveit
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.